Production (Stage)
Pacific Biosciences of California, Inc.
PACB
$1.14
$0.1414.00%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -445.01% | 102.89% | 9.19% | -148.19% | 11.18% |
| Total Depreciation and Amortization | 3,002.87% | -6.41% | 195.12% | 193.77% | 166.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.55% | -355.31% | 86.12% | 493.43% | -50.43% |
| Change in Net Operating Assets | 90.58% | 208.10% | -37.10% | -240.43% | 41.23% |
| Cash from Operations | 41.79% | 46.75% | 30.25% | -30.00% | 20.07% |
| Capital Expenditure | 64.19% | 20.11% | 194.82% | 34.79% | -4.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 254.09% | 192.73% | -90.84% | 181.31% | 56.04% |
| Cash from Investing | 232.51% | 187.48% | -90.48% | 177.94% | 52.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -11,180.90% | 100.00% | 67.31% | 24.22% |
| Issuance of Common Stock | -71.57% | -100.00% | -82.20% | -100.00% | -96.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 38.85% | -- | -- | -- |
| Cash from Financing | -70.11% | 38.48% | 203.97% | 96.78% | -96.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.04% | 89.01% | -112.24% | 115.46% | -459.25% |